ConductScience.org, home

Trial · NCT05604794

A Retrospective Effectiveness Trial of Ketamine-Assisted Psychotherapy in Adult Patients Coping With Mental Health

NCT05604794, Phase 4, Completed, Field Trip Health; results first posted 2023-05-12

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. A Retrospective Effectiveness Trial of Ketamine-Assisted Psychotherapy in Adult Patients Coping With Mental Health. Trials, record NCT05604794. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT05604794

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
A Retrospective Effectiveness Trial of Ketamine-Assisted Psychotherapy in Adult Patients Coping With Mental Health
NCT number
NCT05604794
Status
Completed
Phases
Phase 4
Enrollment
1,806 participants, actual
Lead sponsor
Field Trip Health
Conditions
Depression, Anxiety, Post Traumatic Stress Disorder
Interventions
Ketamine-Assisted Psychotherapy (KAP)
First posted
2022-11-03
Last updated
2024-03-20
Results first posted
2023-05-12
Limitations and caveats
Based on feedback from the peer review process, this study should be considered a cohort study rather than a trial. The high attrition rate may limit validity of results.

Source ClinicalTrials.gov

Registered outcomes9

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
Primary9-item Patient Health Questionnaire (PHQ-9)Change from 3 months compared to baselineSelf-reported measure of depression, ranging from 0-27. Higher scores are worse.
Primary7-item Generalized Anxiety Disorder Measure (GAD-7)Change from 3 months compared to baselineSelf-reported measure of anxiety, ranging from 0-21. Higher scores are worse.
Primary6-item PTSD Checklist (PCL-6)Change from 3 months compared to baselineSelf-reported measure of post traumatic stress, ranging from 6-30. Higher scores are worse.
Secondary9-item Patient Health Questionnaire (PHQ-9)Change from 1 month compared to baselineSelf-reported measure of depression, ranging from 0-27.
Secondary9-item Patient Health Questionnaire (PHQ-9)Change from 6 months compared to baselineSelf-reported measure of depression, ranging from 0-27.
Secondary7-item Generalized Anxiety Disorder Measure (GAD-7)Change from 1 month compared to baselineSelf-reported measure of anxiety, ranging from 0-21.
Secondary7-item Generalized Anxiety Disorder Measure (GAD-7)Change from 6 months compared to baselineSelf-reported measure of anxiety, ranging from 0-21.
Secondary6-item PTSD Checklist (PCL-6)Change from 1 month compared to baselineSelf-reported measure of post traumatic stress, ranging from 6-30.
Secondary6-item PTSD Checklist (PCL-6)Change from 6 months compared to baselineSelf-reported measure of post traumatic stress, ranging from 6-30.

Outcomes9

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

TypeOutcomeTime framePopulationUnitsMeasured as
PRIMARY9-item Patient Health Questionnaire (PHQ-9)Change from 3 months compared to baselineNumber analysed after attrition.units on a scaleMEAN
PRIMARY7-item Generalized Anxiety Disorder Measure (GAD-7)Change from 3 months compared to baselineNumber analysed after attrition.units on a scaleMEAN
PRIMARY6-item PTSD Checklist (PCL-6)Change from 3 months compared to baselineNumber analysed after attrition.units on a scaleMEAN
SECONDARY9-item Patient Health Questionnaire (PHQ-9)Change from 1 month compared to baselineunits on a scaleMEAN
SECONDARY9-item Patient Health Questionnaire (PHQ-9)Change from 6 months compared to baselineunits on a scaleMEAN
SECONDARY7-item Generalized Anxiety Disorder Measure (GAD-7)Change from 1 month compared to baselineunits on a scaleMEAN
SECONDARY7-item Generalized Anxiety Disorder Measure (GAD-7)Change from 6 months compared to baselineunits on a scaleMEAN
SECONDARY6-item PTSD Checklist (PCL-6)Change from 1 month compared to baselineunits on a scaleMEAN
SECONDARY6-item PTSD Checklist (PCL-6)Change from 6 months compared to baselineunits on a scaleMEAN

Results by group9

Each measurement the trial posted, group by group, in the words and numbers it posted.

OutcomeGroupCategoryValueSpreadUnits
9-item Patient Health Questionnaire (PHQ-9)Clients-3.2395% Confidence Interval -3.57 to -2.90units on a scale
7-item Generalized Anxiety Disorder Measure (GAD-7)Clients-4.8095% Confidence Interval -5.17 to -4.44units on a scale
6-item PTSD Checklist (PCL-6)Clients-4.2495% Confidence Interval -4.60 to -3.87units on a scale
9-item Patient Health Questionnaire (PHQ-9)Clients-3.2395% Confidence Interval -3.57 to -2.90units on a scale
9-item Patient Health Questionnaire (PHQ-9)Clients-4.7495% Confidence Interval -5.68 to -3.80units on a scale
7-item Generalized Anxiety Disorder Measure (GAD-7)Clients-2.6595% Confidence Interval -2.95 to -2.34units on a scale
7-item Generalized Anxiety Disorder Measure (GAD-7)Clients-4.1095% Confidence Interval -5.02 to -3.18units on a scale
6-item PTSD Checklist (PCL-6)Clients-2.1495% Confidence Interval -2.44 to -1.83units on a scale
6-item PTSD Checklist (PCL-6)Clients-3.4495% Confidence Interval -4.38 to -2.50units on a scale

Participant flow3

How many started, completed or left each group, period by period.

PeriodMilestoneGroupParticipantsUnits counted
Overall StudySTARTEDClients1,806
Overall StudyCOMPLETEDClients94
Overall StudyNOT COMPLETEDClients1,712

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals3

The totals the trial posted for each group.

TotalGroupAffectedAt risk
Total, all-cause mortalityClients01,806
Total, other adverse eventsClients01,806
Total, serious adverse eventsClients01,806

Papers0

The papers the trial lists on ClinicalTrials.gov.

None in this release.

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT05604794

GET https://conductscience.org/api/trials/v1/NCT05604794/registered